Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1195961-07-9

Post Buying Request

1195961-07-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1195961-07-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1195961-07-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,5,9,6 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1195961-07:
(9*1)+(8*1)+(7*9)+(6*5)+(5*9)+(4*6)+(3*1)+(2*0)+(1*7)=189
189 % 10 = 9
So 1195961-07-9 is a valid CAS Registry Number.

1195961-07-9Downstream Products

1195961-07-9Relevant articles and documents

Discovery of novel putative inhibitors of UDP-GlcNAc 2-epimerase as potent antibacterial agents

Xu, Yong,Brenning, Benjamin,Clifford, Adrianne,Vollmer, David,Bearss, Jared,Jones, Carissa,Mccarthy, Virgil,Shi, Chongtie,Wolfe, Bradley,Aavula, Bhasker,Warner, Steve,Bearss, David J.,McCullar, Michael V.,Schuch, Raymond,Pelzek, Adam,Bhaskaran, Shyam S.,Stebbins, C. Erec,Goldberg, Allan R.,Fischetti, Vincent A.,Vankayalapati, Hariprasad

supporting information, p. 1142 - 1147 (2014/01/06)

We present the discovery and optimization of a novel series of inhibitors of bacterial UDP-N-acetylglucosamine 2-epimerase (called 2-epimerase in this letter). Starting from virtual screening hits, the activity of various inhibitory molecules was optimized using a combination of structure-based and rational design approaches. We successfully designed and identified a 2-epimerase inhibitor (compound 12-ES-Na, that we named Epimerox), which blocked the growth of methicillin-resistant Staphylococcus aureus (MRSA) at 3.9 μM MIC (minimum inhibitory concentration) and showed potent broad-range activity against all Gram-positive bacteria that were tested. Additionally a microplate coupled assay was performed to further confirm that the 2-epimerase inhibition of Epimerox was through a target-specific mechanism. Furthermore, Epimerox demonstrated in vivo efficacy and had a pharmacokinetic profile that is consonant with it being developed into a promising new antibiotic agent for treatment of infections caused by Gram-positive bacteria.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1195961-07-9